Shelley B Thunen's Net Worth

$4.68 Million

Estimate Recalculated Apr 18, 2024 05:23PM EST

Who is Shelley B Thunen?

Shelley B Thunen has an estimated net worth of $4.68 Million. This is based on reported shares across multiple companies, which include RxSight, Inc., INTRALASE CORP, Restoration Robotics, Inc., AEON Biopharma, Inc., and ENDOLOGIX INC /DE/.

SEC CIK

Shelley B Thunen's CIK is 0001297491

Past Insider Trading and Trends

2013 was Shelley B Thunen's most active year for acquiring shares with 3 total transactions. Shelley B Thunen's most active month to acquire stocks was the month of December. 2006 was Shelley B Thunen's most active year for disposing of shares, totalling 78 transactions. Shelley B Thunen's most active month to dispose stocks was the month of January. 2024 saw Shelley B Thunen paying a total of $498,651.76 for 36,272 shares, this is the most they've acquired in one year. In 2007 Shelley B Thunen cashed out on 332,174 shares for a total of $5,413,464.92, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RxSight, Inc. (RXST) Snapshot price: $47.23

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-70.42%
-20.00K
$49.90
-$997,946.23
8.4K
Apr 1
Form 4
—
0
—
—
0
Mar 4
Form 4
—
0
$35.99
-$407,742.65
13.69K
Mar 1
Form 4
+101.61%
6.9K
$29.99
-$778,964.25
13.69K
Feb 5 - Feb 6
Form 4
+196.42%
4.5K
$30.43
-$998,054.08
6.79K
Jan 26
Form 4
—
0
$27.42
-$236,425.75
2.29K
Jan 2
Form 4
-39.45%
-20.00K
$27.47
-$1,261,310.00
30.69K
Scheduled
Dec 15
Form 4
—
0
—
—
0
Mar 9
Form 4
—
0
—
—
0
Jul 31
Form 3
—
0
—
—
0
No matching records found

INTRALASE CORP No price found

EVP & CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-89.05K
$25.00
-$2,226,150.00
0
Apr 2
Form 4
+82.58%
14.72K
$1.44
$21,218.85
32.55K
Mar 29
Form 4
+1,208.88%
16.46K
$13.37
$24.83
17.83K
Mar 28
Form 4
—
0
—
—
0
Apr 28
Form 4
-100.00%
-8.38K
$20.29
-$169,951.38
0
Scheduled
Mar 22
Form 4
-10.66%
-1.00K
$19.35
-$19,353.00
8.38K
Scheduled
Feb 22
Form 4
-79.38%
-36.10K
$19.08
-$688,638.71
9.38K
Scheduled
Feb 22
Form 4
-19.33%
-10.90K
$18.64
-$203,174.94
45.48K
Scheduled
Feb 22
Form 4
—
0
—
—
0
Apr 27
Form 3
—
0
—
—
0
No matching records found

Restoration Robotics, Inc. (VERO) Snapshot price: $1.26

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 13
Form 3
—
0
—
—
0
No matching records found

AEON Biopharma, Inc. (AEON) Snapshot price: $9.01

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 19
Form 4
—
0
—
—
0
Aug 14
Form 3
—
0
—
—
0
No matching records found

ENDOLOGIX INC /DE/ No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-68.25%
-36.85K
—
—
17.14K
Oct 19
Form 4
+3.02%
1.58K
$16.45
-$15,693.30
53.99K
May 22
Form 4
+4.07%
2.15K
$15.77
-$26,383.21
54.95K
Feb 27
Form 4
+40.37%
15.19K
—
—
52.8K
May 22
Form 4
∞
37.62K
$13.85
-$33,018.40
37.62K
Jan 2 - Mar 11
Form 4
∞
40K
—
—
40K
Jan 2
Form 3
—
0
—
—
0
No matching records found